mozavaptan has been researched along with arginine in 1 studies
| Studies (mozavaptan) | Trials (mozavaptan) | Recent Studies (post-2010) (mozavaptan) | Studies (arginine) | Trials (arginine) | Recent Studies (post-2010) (arginine) |
|---|---|---|---|---|---|
| 165 | 8 | 24 | 46,388 | 1,688 | 11,176 |
| Protein | Taxonomy | mozavaptan (IC50) | arginine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 283 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Aki, Y; He, H; Iwao, H; Kiyomoto, H; Tamaki, T; Yoshida, H | 1 |
1 other study(ies) available for mozavaptan and arginine
| Article | Year |
|---|---|
Nitric oxide may participate in V2 vasopressin-receptor-mediated renal vasodilation.
Topics: Animals; Arginine; Arginine Vasopressin; Benzazepines; Blood Pressure; Dogs; Female; Male; Nitric Oxide; Nitroarginine; Receptors, Vasopressin; Renal Circulation; Vascular Resistance; Vasodilation | 1994 |